Coordinating sites

UCL Innovative Clinical Trials Unit

From April 2026, the MRC Clinical Trials Unit will become the UCL Innovative Clinical Trials Unit. Find out more on our website here.

The MRC Clinical Trials Unit at UCL has always been defined by its dedication to impactful research, innovation, its culture of collaboration and mentorship, and its commitment to improving global health. The Innovative Clinical Trials Unit is committed to continuing to fulfil the mission of smarter studies and global impact, leading to better health. We will continue to successfully deliver new and ongoing studies, collaborating with partners around the world.

As well as providing funding for the ARCHERY trial, our team at the InCTU will oversee the everyday coordination of the study. Visit the InCTU website to find out more about the unit's work.

The ARCHERY team at the InCTU currently includes:

Ajay Aggarwal - Chief Investigator

Claire Murphy - Clinical Project Manager

Christos Maniatis - Trial Manager

Isabella Jacques - Data Manager

Matthew Nankivell - Senior Statistician 

Former ARCHERY team members at the MRC CTU:

Lee Barker - Database Programmer/Systems Analyst

Chiara Borg - Clinical Project Manager for Data Management

Carol Roach - Trial Manager

Brendan Mauger - Senior Analyst Programmer

Maggie Hook - Clinical Data Management Specialist

MD Anderson Cancer Centre

The University of Texas' MD Anderson Cancer Centre conducts one of the world's largest clinical trials programs, offering thousands of clinical trials covering prevention, diagnosis, treatment and survivorship of cancer. The Court Lab at MD Anderson will be responsible for applying the AI radiotherapy planning to patient CT scans. Visit the Court Lab website to find out more about their research.

The ARCHERY team at MD Anderson includes:

Laurence Court - Associate Professor

Lifei Joy Zhang - Manager in Scientific Computing Research

Tucker Netherton - Assistant Professor

Callistus Nguyen - Computational Scientist

Raphael Douglas - Senior Research Assistant in Radiation Physics 

The Radiotherapy Trials Quality Assurance (RTTQA) Group

The Radiotherapy Trials Quality Assurance (RTTQA) Group is an independent, multidisciplinary network, based across a number of UK NHS sites, with the remit to monitor safety, consistency and accuracy of treatment within clinical trials. Within ARCHERY, the RTTQA group team at the Mount Vernon Cancer Centre will provide an assessment of the AI radiotherapy treatment plans as to whether they can be considered clinically acceptable.

The ARCHERY team at the RTTQA at Mount Vernon Cancer Centre includes:

Elizabeth Miles - RTTQA Group Lead

Mariana Kroiss - Senior Radiotherapy Physicist

Peter Hoskin - Professor of Clinical Oncology

Ghent University

To quantify the cost and resource savings of using the RPA compared to the manual approach, the approved time-driven activity-based costing model developed by the European Society for Radiotherapy and Oncology (ESTRO) Health Economics in Radiation Oncology (HERO) project will be used. The HERO project is co-chaired by Yolande Lievens at Ghent University. Time-and-motion studies will be undertaken to populate the costing model. Visit the HERO page on the ESTRO website to find out more about the project.

The ARCHERY team at Ghent University includes:

Yolande Lievens - Chair of ESTRO and Co-Chair of HERO

Barbara Vanderstraeten - Radiation Physicist